NeuroMetrix

NeuroMetrix, Inc. is a healthcare company specializing in the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, with a particular focus on diabetic neuropathies. The company develops and markets wearable neuro-stimulation devices and point-of-care diagnostic tests aimed at addressing chronic health conditions such as chronic pain, sleep disorders, and diabetes. Its product offerings include Quell, a device designed for chronic pain relief; DPNCheck, a diagnostic test for diabetic peripheral neuropathy; the ADVANCE system for traditional nerve conduction studies; and SENSUS, a therapy device utilizing transcutaneous electrical nerve stimulation. NeuroMetrix serves a diverse customer base, including health care professionals, managed care organizations, and various medical specialists. The company operates in multiple regions, including the United States, Europe, Japan, China, the Middle East, and Mexico, and has established a strategic collaboration with GlaxoSmithKline. Founded in 1996, NeuroMetrix is headquartered in Woburn, Massachusetts.

Brandi Damkier

Vice President of Clinical Partnerships

1 past transactions

Eyetel Imaging

Acquisition in 2007
EyeTel Imaging, founded in 1996, specializes in developing advanced imaging technologies aimed at preventing vision loss associated with undetected diabetic retinopathy. The company's flagship product, the EyeTel Retinal Imaging System, utilizes the DigiScope, a semi-automated fundus camera that captures high-quality images, facilitating the detection of various ocular conditions, including age-related macular degeneration and glaucoma. EyeTel also operates the EyeTel Reading Center, a telemedicine service that offers expert analysis of patient images by trained specialists, ensuring accurate diagnoses. Collaborating with the Wilmer Eye Institute and manufacturing partner Topzone in China, EyeTel has successfully enhanced its retinal imaging capabilities while maintaining a commitment to cost-effectiveness and ease of use. The technology is clinically validated and designed for primary care settings, reflecting the company's dedication to improving patient care in a convenient manner.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.